98.5% Purity Antibiotic 70458 -96-7 Norfacin

Model NO.
70458-96-7
Offer Documents
COA
Color
White to Slightly Yellow Crystalline Powder
Transport Package
25kg/Drum
Specification
98.5%
Trademark
blue lake
Origin
Jiangxi China
Production Capacity
60 Tons Per Month
Reference Price
Please contact us for quote
Contact Us

Product Description

PART A: Medicine Description
Ofloxacin  is a  quinolone antibiotic  useful for the treatment of a number of  bacterial infections . When taken  by mouth  or  injection into a vein , these include  pneumonia ,  cellulitis ,  urinary tract infections ,  prostatitis ,  plague , and certain types of  infectious diarrhea . Other uses, along with other medications, include treating  multidrug resistant tuberculosis . An  eye drop  may be used for a  superficial bacterial infection of the eye  and an  ear drop  may be used for  otitis media  when a hole in the  ear drum  is present.


PART B: Medicine Functions
Ofloxacin is used in the treatment of bacterial infections such as:

  • Acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD)
  • Community-acquired pneumonia
  • Uncomplicated skin and skin structure infections
  • Nongonococcal urethritis and cervicitis
  • Epididymitis
  • Mixed Infections of the urethra and cervix
  • Acute pelvic inflammatory disease
  • Uncomplicated cystitis
  • Complicated urinary tract infections
  • Prostatitis
  • Acute, uncomplicated urethral and cervical gonorrhea

Ofloxacin has not been shown to be effective in the treatment of syphilis.Ofloxacin is no longer considered a first-line treatment for gonorrhea, because of bacterial resistance.
 

98.5% Purity Antibiotic 70458-96-7 Norfacin

 
Property Name Property Value Reference
Molecular Weight 319.33 Computed by PubChem 2.1 (PubChem release 2023.05.07)
XLogP3 -1 Computed by XLogP3 3.0 (PubChem release 2023.05.07)
Hydrogen Bond Donor Count 2 Computed by Cactvs 3.4.8.18 (PubChem release 2023.05.07)
Hydrogen Bond Acceptor Count 7 Computed by Cactvs 3.4.8.18 (PubChem release 2023.05.07)
Rotatable Bond Count 3 Computed by Cactvs 3.4.8.18 (PubChem release 2023.05.07)
Exact Mass 319.13321961 Computed by PubChem 2.1 (PubChem release 2023.05.07)
Monoisotopic Mass 319.13321961 Computed by PubChem 2.1 (PubChem release 2023.05.07)
Heavy Atom Count 23 Computed by PubChem
Complexity 519 Computed by Cactvs 3.4.8.18 (PubChem release 2023.05.07)
Isotope Atom Count 0 Computed by PubChem
Defined Atom Stereocenter Count 0 Computed by PubChem
Undefined Atom Stereocenter Count 0 Computed by PubChem
Defined Bond Stereocenter Count 0 Computed by PubChem
Undefined Bond Stereocenter Count 0 Computed by PubChem
Covalently-Bonded Unit Count 1 Computed by PubChem
Compound Is Canonicalized Yes Computed by PubChem (release 2023.05.07)
 
PART  C: Company Profile
98.5% Purity Antibiotic 70458-96-7 Norfacin 98.5% Purity Antibiotic 70458-96-7 Norfacin

98.5% Purity Antibiotic 70458-96-7 Norfacin  
98.5% Purity Antibiotic 70458-96-7 Norfacin 98.5% Purity Antibiotic 70458-96-7 Norfacin
  PART  D : Contact Information
Website: 

 


 



 











 

 

Pharmaceutical Intermediate

GOUV.NE, 2023